1. To study the possible role of nitric oxide (NO free radical; NO-) or NO-containing compounds in the non-adrenergic, non-cholinergic (NANC) relaxations, we observed the effects of carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (C-PTIO; a newly synthesized NO scavenger) on NANC relaxations in the cat airway. In addition, we also observed the effects of C-PTIO on excitatory junction potentials (EJPs), since NO-has a prejunctional action on transmitter release. 4. After pretreatment of the bronchial tissues with a-chymotrypsin (1 unit ml-') for 30 min in order to inhibit any response to peptides, EFS evoked monophasic NANC relaxation.C-PTIO (10--10-4 M) dose-dependently suppressed, and at a concentration of 10-4 M almost halved, the amplitude of NANC relaxation. Additional application of L-NAME further reduced the C-PTIO-resistant NANC relaxation to 20-30 % of the initial value. 5. C-PTIO (10-4 M) enhanced the EJP amplitude evoked by single EFS in the trachea but not in the bronchi. However, C-PTIO enhanced the summation of the EJPs to repeated stimulation to a similar extent in the tracheal and bronchial tissues. Simultaneous application of C-PTIO and L-NAME did not further enhance the summation. 6. These results indicate that NO-and NO-containing compounds are involved in the L-NAME-sensitive NANC relaxation in the cat airway, and that only NO-has a prejunctional action which inhibits excitatory neuroeffector transmission.We reported that at least two neurotransmitters, possibly NO or NO-containing compounds and a peptide such as vasoactive intestinal polypeptide (VIP), are involved in the inhibitory non-adrenergic, non-cholinergic (NANC) neurotransmission in the cat airway and that the distribution profile of the two components differs in the central and peripheral airways (Jing, Inoue, Tashiro, Takahashi & Ito, 1995;Takahashi, Tanaka, Abdullah, Jing, Inoue & Ito, 1995 .